methamphetamine has been researched along with muromonab-cd3 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braden, BB; Butler, TR; Prendergast, MA; Self, RL; Smith, KJ | 1 |
1 other study(ies) available for methamphetamine and muromonab-cd3
Article | Year |
---|---|
Potentiation of N-methyl-D-aspartate receptor-mediated neuronal injury during methamphetamine withdrawal in vitro requires co-activation of IP3 receptors.
Topics: Animals; Animals, Newborn; Cell Death; Cell Survival; Central Nervous System Stimulants; Drug Interactions; Drug Synergism; Excitatory Amino Acid Antagonists; Female; Hippocampus; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Male; Methamphetamine; Nerve Degeneration; Organ Culture Techniques; Oxazoles; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2008 |